David P. Rosenbaum

2.7k total citations
71 papers, 1.6k citations indexed

About

David P. Rosenbaum is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Molecular Biology. According to data from OpenAlex, David P. Rosenbaum has authored 71 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 20 papers in Nephrology and 19 papers in Molecular Biology. Recurrent topics in David P. Rosenbaum's work include Gastrointestinal motility and disorders (16 papers), Parathyroid Disorders and Treatments (16 papers) and Ion Transport and Channel Regulation (13 papers). David P. Rosenbaum is often cited by papers focused on Gastrointestinal motility and disorders (16 papers), Parathyroid Disorders and Treatments (16 papers) and Ion Transport and Channel Regulation (13 papers). David P. Rosenbaum collaborates with scholars based in United States, Sweden and United Kingdom. David P. Rosenbaum's co-authors include Anthony Lembo, William D. Chey, Glenn M. Chertow, Bergur V. Stefánsson, Andrew T. Yan, Geoffrey A. Block, Steven M. Brunelli, Karthik Ramakrishnan, Donna E. Jensen and Nils‐Olov Stålhammar and has published in prestigious journals such as Gastroenterology, Kidney International and Journal of Medicinal Chemistry.

In The Last Decade

David P. Rosenbaum

71 papers receiving 1.6k citations

Peers

David P. Rosenbaum

NEPHR

SURGE

PRM

GASTR

Man S. Oh United States

Angelos M. Kappas Greece

Cheng‐Jui Lin Taiwan

Hugh J. Carroll United States

Manuel Pestana Portugal

Joshua Weissgarten Israel

Henriëtte de Loor Belgium

Richard G. Fiddian-Green United States

Maria Aparecida Dalboni Brazil

Shigeru Toyoda Japan

Man S. Oh United States

David P. Rosenbaum

764 ×1.1

NEPHR

294 ×0.7

SURGE

728 ×2.0

PRM

107 ×0.3

GASTR

252 ×0.8

Citations per year, relative to David P. Rosenbaum David P. Rosenbaum (= 1×) peers Man S. Oh

Countries citing papers authored by David P. Rosenbaum

Since Specialization

Citations

This map shows the geographic impact of David P. Rosenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David P. Rosenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David P. Rosenbaum more than expected).

Fields of papers citing papers by David P. Rosenbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David P. Rosenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David P. Rosenbaum. The network helps show where David P. Rosenbaum may publish in the future.

Co-authorship network of co-authors of David P. Rosenbaum

This figure shows the co-authorship network connecting the top 25 collaborators of David P. Rosenbaum. A scholar is included among the top collaborators of David P. Rosenbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David P. Rosenbaum. David P. Rosenbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lembo, Anthony, William D. Chey, Lucinda A. Harris, et al.. (2024). Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis. The American Journal of Gastroenterology. 119(5). 937–945. 6 indexed citations

Sprague, Stuart M., Daniel E. Weiner, Pablo E. Pérgola, et al.. (2024). Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study. Kidney360. 5(5). 732–742. 7 indexed citations

Lacy, Brian E., et al.. (2024). Intestinal Permeability, Irritable Bowel Syndrome with Constipation, and the Role of Sodium-Hydrogen Exchanger Isoform 3 (NHE3). Clinical and Experimental Gastroenterology. Volume 17. 173–183. 2 indexed citations

Chertow, Glenn M., et al.. (2023). Tenapanor Improves Long-Term Control of Hyperphosphatemia in Patients Receiving Maintenance Dialysis: the NORMALIZE Study. Kidney360. 4(11). 1580–1589. 4 indexed citations

Lembo, Anthony, Keith Friedenberg, Ronald Fogel, et al.. (2023). Long‐term safety of tenapanor in patients with irritable bowel syndrome with constipation in the T3MPO‐3 study. Neurogastroenterology & Motility. 35(11). e14658–e14658. 8 indexed citations

Yee, Jerry, David P. Rosenbaum, Jeffrey Jacobs, & Stuart M. Sprague. (2021). Small Intestinal Phosphate Absorption: Novel Therapeutic Implications. American Journal of Nephrology. 52(7). 522–530. 14 indexed citations

King, Andrew J., et al.. (2020). Combination treatment with tenapanor and sevelamer synergistically reduces urinary phosphorus excretion in rats. American Journal of Physiology-Renal Physiology. 320(1). F133–F144. 9 indexed citations

Block, Geoffrey A., David P. Rosenbaum, Andrew T. Yan, & Glenn M. Chertow. (2019). Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis: A Randomized Phase 3 Trial. Journal of the American Society of Nephrology. 30(4). 641–652. 81 indexed citations

Rosenbaum, David P., Andrew T. Yan, & Jeffrey Jacobs. (2018). Pharmacodynamics, Safety, and Tolerability of the NHE3 Inhibitor Tenapanor: Two Trials in Healthy Volunteers. Clinical Drug Investigation. 38(4). 341–351. 43 indexed citations

10.

Pitt, Bertram, et al.. (2018). An Evaluation of the Pharmacodynamics, Safety, and Tolerability of the Potassium Binder RDX7675. The Journal of Clinical Pharmacology. 58(8). 1035–1043. 1 indexed citations

11.

Johansson, Susanne, et al.. (2017). Effects of Tenapanor on Cytochrome P450‐Mediated Drug‐Drug Interactions. Clinical Pharmacology in Drug Development. 6(5). 466–475. 10 indexed citations

12.

Johansson, Susanne, David P. Rosenbaum, Johan Palm, et al.. (2017). Tenapanor administration and the activity of the H⁺‐coupled transporter PepT1 in healthy volunteers. British Journal of Clinical Pharmacology. 83(9). 2008–2014. 10 indexed citations

13.

Verbalis, Joseph G., Howard Ellison, Mary Hobart, et al.. (2016). Tolvaptan and Neurocognitive Function in Mild to Moderate Chronic Hyponatremia: A Randomized Trial (INSIGHT). American Journal of Kidney Diseases. 67(6). 893–901. 42 indexed citations

14.

Cabrera, Claudia, Steven M. Brunelli, David P. Rosenbaum, et al.. (2015). A retrospective, longitudinal study estimating the association between interdialytic weight gain and cardiovascular events and death in hemodialysis patients. BMC Nephrology. 16(1). 113–113. 46 indexed citations

15.

Spencer, Andrew, Eric D. Labonté, David P. Rosenbaum, et al.. (2014). Intestinal Inhibition of the Na ⁺ /H ⁺ Exchanger 3 Prevents Cardiorenal Damage in Rats and Inhibits Na ⁺ Uptake in Humans. Science Translational Medicine. 6(227). 227ra36–227ra36. 126 indexed citations

16.

Bruckert, Éric & David P. Rosenbaum. (2011). Lowering LDL-cholesterol through diet: potential role in the statin era. Current Opinion in Lipidology. 22(1). 43–48. 44 indexed citations

17.

Barraclough, Katherine A., et al.. (2008). Coronary artery calcification scores in patients with chronic kidney disease prior to dialysis: reliability as a trial outcome measure. Nephrology Dialysis Transplantation. 23(10). 3199–3205. 12 indexed citations

18.

Rosenbaum, David P., et al.. (1997). Absorption, Distribution and Excretion of GT31-104, a Novel Bile Acid Sequestrant, in Rats and Dogs After Acute and Subchronic Administration. Journal of Pharmaceutical Sciences. 86(5). 591–595. 22 indexed citations

19.

Kopchok, George E., et al.. (1990). Intraluminal Vascular Ultrasound: Preliminary Report of Dimensional and Morphologic Accuracy. Annals of Vascular Surgery. 4(3). 291–296. 17 indexed citations

20.

Sengupta, S. K., David P. Rosenbaum, Raj K. Sehgal, Bijan Almassian, & Joanne Blondin. (1988). Enantiomers of 7-(2,3-epoxypropoxy)actinomycin D as dual-action DNA-acting antitumor agents. Journal of Medicinal Chemistry. 31(8). 1540–1547. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact